Results
|
1.
|
|
|
2.
|
ENHANCE: results of a global open-label trial of drotrecogin alfa (activated) in children with severe sepsis. [electronic resource] by
- Goldstein, Brahm
- Nadel, Simon
- Peters, Mark
- Barton, Roger
- Machado, Flavia
- Levy, Howard
- Haney, Douglas J
- Utterback, Barbara
- Williams, Mark D
- Giroir, Brett P
Producer: 20061109
In:
Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies vol. 7
Availability: No items available.
|
|
3.
|
International integrated database for the evaluation of severe sepsis and drotrecogin alfa (activated) therapy: 28-day survival and safety. [electronic resource] by
- Laterre, Pierre-Francois
- Nelson, David R
- Macias, William
- Abraham, Edward
- Sashegyi, Andreas
- Williams, Mark D
- Levy, Mitchell
- Levi, Marcel
- Utterback, Barbara
- Vincent, Jean-Louis
Producer: 20070809
In:
Journal of critical care vol. 22
Availability: No items available.
|
|
4.
|
|
|
5.
|
Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism [ISRCTN74215569]. [electronic resource] by
- Kinasewitz, Gary T
- Yan, S Betty
- Basson, Bruce
- Comp, Philip
- Russell, James A
- Cariou, Alain
- Um, Suzane L
- Utterback, Barbara
- Laterre, Pierre-Francois
- Dhainaut, Jean-François
Producer: 20051013
In:
Critical care (London, England) vol. 8
Availability: No items available.
|
|
6.
|
Drotrecogin alfa (activated) in the treatment of severe sepsis patients with multiple-organ dysfunction: data from the PROWESS trial. [electronic resource] by
- Dhainaut, Jean-François
- Laterre, Pierre-François
- Janes, Jonathan M
- Bernard, Gordon R
- Artigas, Antonio
- Bakker, Jan
- Riess, Hanno
- Basson, Bruce R
- Charpentier, Julien
- Utterback, Barbara G
- Vincent, Jean-Louis
Producer: 20031031
In:
Intensive care medicine vol. 29
Availability: No items available.
|
|
7.
|
Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death. [electronic resource] by
- Abraham, Edward
- Laterre, Pierre-François
- Garg, Rekha
- Levy, Howard
- Talwar, Deepak
- Trzaskoma, Benjamin L
- François, Bruno
- Guy, Jeffrey S
- Brückmann, Martina
- Rea-Neto, Alvaro
- Rossaint, Rolf
- Perrotin, Dominique
- Sablotzki, Armin
- Arkins, Nancy
- Utterback, Barbara G
- Macias, William L
Producer: 20051006
In:
The New England journal of medicine vol. 353
Availability: No items available.
|
|
8.
|
The clinical evaluation committee in a large multicenter phase 3 trial of drotrecogin alfa (activated) in patients with severe sepsis (PROWESS): role, methodology, and results. [electronic resource] by
- Dhainaut, Jean-François
- Laterre, Pierre-François
- LaRosa, Steven P
- Levy, Howard
- Garber, Gary E
- Heiselman, Darell
- Kinasewitz, Gary T
- Light, R Bruce
- Morris, Peter
- Schein, Roland
- Sollet, Jean-Pierre
- Bates, Becky M
- Utterback, Barbara G
- Maki, Dennis
Producer: 20031117
In:
Critical care medicine vol. 31
Availability: No items available.
|
|
9.
|
Safety, pharmacokinetics, and pharmacodynamics of drotrecogin alfa (activated) in children with severe sepsis. [electronic resource] by
- Barton, Phil
- Kalil, Andre C
- Nadel, Simon
- Goldstein, Brahm
- Okhuysen-Cawley, Regina
- Brilli, Richard J
- Takano, Jeanne S
- Martin, Lynn D
- Quint, Peter
- Yeh, Timothy S
- Dalton, Heidi J
- Gessouron, Morris R
- Brown, Kellie E
- Betts, Helen
- Levin, Michael
- Macias, William L
- Small, David S
- Wyss, Virginia L
- Bates, Becky M
- Utterback, Barbara G
- Giroir, Brett P
Producer: 20040128
In:
Pediatrics vol. 113
Availability: No items available.
|